# FDA Inspection 1269032 - Qilu Pharmaceutical Co., Ltd. - April 04, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-co-ltd/29827c34-c95e-4eef-b18c-dc19db3e793f
Source feed: FDA_Inspections

> FDA Inspection 1269032 for Qilu Pharmaceutical Co., Ltd. on April 04, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269032
- Company Name: Qilu Pharmaceutical Co., Ltd.
- Inspection Date: 2025-04-04
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269032 - 2025-04-04](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-co-ltd/33ea0461-6662-409b-9b68-349775329634)
- [FDA Inspection 1088395 - 2019-02-22](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-co-ltd/34945e69-b9f9-4aaf-8d2b-90f401ee3bf2)
- [FDA Inspection 1048729 - 2018-03-09](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-co-ltd/15456011-b450-4458-b2ee-95ba67cc22d3)
- [FDA Inspection 989208 - 2016-09-23](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-co-ltd/17c953fd-decb-49f5-988d-a7947f23b71f)
- [FDA Inspection 855751 - 2013-10-25](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-co-ltd/61eb820b-0f6f-40bb-b756-e8a356726b80)

Company: https://www.globalkeysolutions.net/companies/qilu-pharmaceutical-co-ltd/8313b57b-176c-41ab-89cc-e3dadfd3a0fc

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c